Genomtec S.A. (WSE:GMT)
Poland · Delayed Price · Currency is PLN 6.41
-0.18 (-2.73%)
Sep 18, 2025, 3:45 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 97.97 million as of September 18, 2025. Its market cap has decreased by -17.66% in one year.
Market Cap
97.97M
Enterprise Value
86.71M
Revenue
6.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.41
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 97.97M, a decrease of -11.37%. That is a compound annual growth rate of -2.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 97.97M | -6.45% |
| Dec 30, 2024 | 104.73M | -21.25% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | 110.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 7.03B |
| NEUCA | 3.18B |
| Synektik Spólka Akcyjna | 2.07B |
| Voxel | 1.78B |
| Celon Pharma | 1.20B |
| Ryvu Therapeutics | 633.49M |
| Selvita | 616.74M |
| Centrum Medyczne ENEL-MED | 497.73M |